A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer

Michael A. O’Donnell; Sharwan Singh; Rajeev Sood; Jitendra Amlani; H. Krishnamoorthy; Ketan Shukla; Nayan Mohanty; Sushil Bhatia; Bhaswat Chakraborty; Nirav Desai; Rajiv Modi; Chandreshwar Shukla; Kapil Vachhani; Rashmi Patel; Anup Kundu; Bakulesh Khamar

doi:10.3233/blc-190211

A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer

Bladder Cancer ◽

10.3233/blc-190211 ◽

2019 ◽

Vol 5 (2) ◽

pp. 171-180 ◽

Cited By ~ 1

Author(s):

Michael A. O’Donnell ◽

Sharwan Singh ◽

Rajeev Sood ◽

Jitendra Amlani ◽

H. Krishnamoorthy ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Tlr2 Agonist ◽

Muscle Invasive

Download Full-text

Faculty Opinions recommendation of Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739122585.793581022 ◽

2020 ◽

Author(s):

Otto Hemminki

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Repeat Dose ◽

Open Label ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial

European Urology ◽

10.1016/s0302-2838(21)01132-5 ◽

2021 ◽

Vol 79 ◽

pp. S1043-S1044

Author(s):

D.M. Carrión Monsalve ◽

J. Gomez Rivas ◽

C.R. Trelles ◽

C. Ballesteros Ruiz ◽

M. Alvarez-Maestro ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Preliminary Results ◽

Muscle Invasive

Download Full-text

Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.11.001 ◽

2021 ◽

Author(s):

Giovanni Cochetti ◽

Jacopo Adolfo Rossi de Vermandois ◽

Vincenza Maulà ◽

Luigi Cari ◽

Rosy Cagnani ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Diagnostic Performance ◽

Invasive Bladder Cancer ◽

Photodynamic Diagnosis ◽

Single Centre ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: interim analysis of the PRECAVE randomized clinical trial.

10.37554/en-j.arch.esp.urol-20210704-3511-30 ◽

2021 ◽

Author(s):

Diego Carrión ◽

Juan Gómez Rivas ◽

Cristina Ballesteros Ruiz ◽

Mario Álvarez-Maestro ◽

Emilio Ríos González ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Interim Analysis ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

European Urology Focus ◽

10.1016/j.euf.2018.02.005 ◽

2019 ◽

Vol 5 (5) ◽

pp. 849-852

Author(s):

Peter F.A. Mulders ◽

Luis Martínez-Piñeiro ◽

Axel Heidenreich ◽

Marko Babjuk ◽

Marc Colombel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Lessons Learned ◽

Invasive Bladder Cancer ◽

Phase 2 ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis

European Urology Open Science ◽

10.1016/s2666-1683(20)33373-5 ◽

2020 ◽

Vol 19 ◽

pp. e1175-e1176

Author(s):

C. Garcia Alvarez ◽

A.C. Plata Bello ◽

J. Plata Bello ◽

M.A. Tamayo Jover ◽

T. Concepción Masip

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Mitomycin C ◽

Transurethral Resection ◽

Early Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Prospective Randomized Clinical Trial ◽

Muscle Invasive

Download Full-text

Re: Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group

The Journal of Urology ◽

10.1016/j.juro.2018.02.035 ◽

2018 ◽

Vol 199 (5) ◽

pp. 1111-1112

Author(s):

Sam S. Chang

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

End Points ◽

Cancer Group ◽

Clinical Trial Designs ◽

Muscle Invasive

Download Full-text

A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer

International Journal of Hyperthermia ◽

10.3109/02656736.2014.900194 ◽

2014 ◽

Vol 30 (3) ◽

pp. 166-170 ◽

Cited By ~ 22

Author(s):

Alejandro Sousa ◽

Brant A. Inman ◽

Idelfonso Piñeiro ◽

Victor Monserrat ◽

Alberto Pérez ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

CELECOXIB FOR THE TREATMENT OF NON MUSCLE INVASIVE BLADDER CANCER. RESULTS FROM THE FIRST PHASE II CLINICAL TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(08)60909-4 ◽

2008 ◽

Vol 7 (3) ◽

pp. 299 ◽

Cited By ~ 1

Author(s):

V. Pagliarulo ◽

I. Martines ◽

S. Telari ◽

P. Ancona ◽

P. Trerotoli ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Re: Jarow JP et al.: Clinical Trial Design For the Development of New Therapies for Non–muscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop (Urology 2014;83:262-265)

Urology ◽

10.1016/j.urology.2014.03.034 ◽

2014 ◽

Vol 84 (2) ◽

pp. 494-495 ◽

Cited By ~ 2

Author(s):

John Amrhein ◽

Ashish M. Kamat ◽

Alvaro Morales

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Drug Administration ◽

Trial Design ◽

Food And Drug Administration ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

American Urological Association

Download Full-text